Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Persian Gulf Jellyfish (Cassiopea Andromeda) Venom Fractions Induce Selective Injury and Cytochrome C Release in Mitochondria Obtained From Breast Adenocarcinoma Patients Publisher Pubmed



Mirshamsi MR1 ; Omranipour R2 ; Vazirizadeh A3 ; Fakhri A1 ; Zangeneh F1 ; Mohebbi GH4 ; Seyedian R5 ; Pourahmad J1
Authors

Source: Asian Pacific Journal of Cancer Prevention Published:2017


Abstract

Objective: This study was conducted to investigate whether fractions of jellyfish Cassiope andromeda venom, could selectively induce toxicity on mitochondria isolated from cancer tissue of patients with breast adenocarcinomas. Methods: Firstly, we extracted two fractions, (f1 and f2) from crude jellyfish venom by gel filtration on Sephadex G-200.Then different dilutions of these extracted fractions were applied to mitochondria isolated from human breast tumoral- and extra-tumoral tissues. Parameters of mitochondrial toxicity including generation of reactive oxygen species (ROS), mitochondrial membrane potential (MMP) collapse, swelling, cytochrome c release, activation of caspase3 and apoptosis were then assayed. Result: Our results demonstrate that fraction 2 of Cassiopea andromeda crude venom significantly (P < 0.05) decreased mitochondrial succinate dehydrogenase activity, increased mitochondrial ROS production, induced mitochondrial swelling, MMP collapse and cytochrome c release, activated caspase3 and induced apoptosis only in tumoral mitochondria, and not in mitochondria obtained from extra-tumoral tissue (P < 0.05). Conclusion: In conclusion this study suggested that fraction 2 of Cassiopea andromeda crude venom selectively induces ROS mediated cytotoxicity by directly targeting mitochondria isolated from human breast tumor tissue.
Other Related Docs
13. Mitochondria and Cancer Therapy, Mitochondrial Metabolism: An Approach to Disease Management (2021)
15. Mitochondrial Contribution to Cell Death, Mitochondrial Metabolism: An Approach to Disease Management (2021)